Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, MiRNA-based therapy for Pulmonary arterial hypertension: MiRNA-218 protects against development of pulmonary arterial hypertension via down regulation of its target gene, 17/September/2014, 10.40 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
Significance: This study suggests that MiRNA-218, by down regulating the expression of its target gene, it may inhibit the development of pulmonary arterial hypertension. Thus, pharmacological formulations encompassing “MiRNA-218 inhibitors” may be used to treat pulmonary arterial hypertension.
* Research cooperation